Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary Edema [3] (multiple letters)

Mayo Clinic Proceedings

Volumn 79, Issue 4, 2004, Pages

  Jamieson, Andrew ^a   Abousleiman, Youssif ^a   Mikhail, Nasser E ^b   Wali, Soma ^b   Cope, Dennis ^b   Bell, David S H ^c   Bowlin, Steven J ^d   Koro, Carol E ^d   Kermani, Asra ^e   Garg, Abhimanyu ^e  

^a QUEEN MARGARET HOSPITAL   (United Kingdom)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; LOOP DIURETIC AGENT; METFORMIN; MEVINOLIN; OXYGEN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA; TROGLITAZONE; ANTIDIABETIC AGENT; 2,4 THIAZOLIDINEDIONE; 2,4-THIAZOLIDINEDIONE;

ADULT; CASE REPORT; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; DRUG MECHANISM; DRUG SAFETY; FEMALE; HEART FAILURE; HUMAN; INSULIN TREATMENT; LETTER; LUNG EDEMA; MALE; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN THERAPY; RESPIRATORY DISTRESS; RHABDOMYOLYSIS; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; NOTE; PATIENT SELECTION; DIABETES MELLITUS; DRUG COMBINATION; DRUG INTERACTION; DRUG MONITORING; RISK FACTOR; SAFETY;

ACUTE DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT SELECTION; PULMONARY EDEMA; THIAZOLIDINEDIONES; DIABETES MELLITUS; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; INSULIN; RISK FACTORS; SAFETY;

EID: 12144288524     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.4.571     Document Type: Letter

References (1)

1. A Kermani A Garg Thiazolidinedione-associated congestive heart failure and pulmonary edema Mayo Clin Proc 78 2003 1088 1091